Literature DB >> 22076061

Exploration of the binding of curcumin analogues to human P450 2C9 based on docking and molecular dynamics simulation.

Rongwei Shi1, Yin Wang, Xiaolei Zhu, Xiaohua Lu.   

Abstract

Molecular docking and molecular dynamics (MD) simulations are used to investigate the interactions of curcumin analogues (CAs) with human cytochrome P450 2 C9 (CYP2C9 or 2 C9) and the conformations of their binding sites. In order to examine conformations of CAs/2 C9 and interaction characteristics of their binding sites, RMSDs, RMSFs, and B-factors are computed, and electrostatic and hydrophobic interactions between CAs and 2 C9 are analyzed and discussed. Results demonstrate that the most CAs studied lie 4~15 Å above the heme of CYP2C9. The presence of CAs makes some residues in bound CYP2C9s become more flexible. In the binding sites of A0/2 C9 and C0/2 C9, the formation of H-bond networks (or CA-water-residue bridges) enhances the interactions between CAs and 2 C9. The stronger inhibitory effects of A0, B0, and C0 on 2 C9 can be ascribed to stronger electrostatic and hydrophobic interactions in the binding sites of CAs/2 C9.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22076061     DOI: 10.1007/s00894-011-1275-1

Source DB:  PubMed          Journal:  J Mol Model        ISSN: 0948-5023            Impact factor:   1.810


  63 in total

1.  CYP2C9 structure-metabolism relationships: substrates, inhibitors, and metabolites.

Authors:  Marie M Ahlström; Marianne Ridderström; Ismael Zamora
Journal:  J Med Chem       Date:  2007-10-04       Impact factor: 7.446

2.  Curcumin--a natural herb with anti-HIV activity.

Authors:  W C Jordan; C R Drew
Journal:  J Natl Med Assoc       Date:  1996-06       Impact factor: 1.798

3.  Curcumin analogs with altered potencies against HIV-1 integrase as probes for biochemical mechanisms of drug action.

Authors:  A Mazumder; N Neamati; S Sunder; J Schulz; H Pertz; E Eich; Y Pommier
Journal:  J Med Chem       Date:  1997-09-12       Impact factor: 7.446

Review 4.  Pharmacophore and three-dimensional quantitative structure activity relationship methods for modeling cytochrome p450 active sites.

Authors:  S Ekins; M J de Groot; J P Jones
Journal:  Drug Metab Dispos       Date:  2001-07       Impact factor: 3.922

5.  Hypocholesteremic effect of curcumin in induced hypercholesteremic rats.

Authors:  T N Patil; M Srinivasan
Journal:  Indian J Exp Biol       Date:  1971-04       Impact factor: 0.818

6.  Inhibition of the HIV-1 and HIV-2 proteases by curcumin and curcumin boron complexes.

Authors:  Z Sui; R Salto; J Li; C Craik; P R Ortiz de Montellano
Journal:  Bioorg Med Chem       Date:  1993-12       Impact factor: 3.641

7.  Quantitative binding models for CYP2C9 based on benzbromarone analogues.

Authors:  Charles W Locuson; Denise A Rock; Jeffrey P Jones
Journal:  Biochemistry       Date:  2004-06-08       Impact factor: 3.162

8.  The metabolism of CYP2C9 and CYP2C19 for gliclazide by homology modeling and docking study.

Authors:  Yuan Yao; Wei-Wei Han; Yi-Han Zhou; Ze-Sheng Li; Qiang Li; Xiao-Yan Chen; Da-Fang Zhong
Journal:  Eur J Med Chem       Date:  2008-05-02       Impact factor: 6.514

9.  Preliminary study on antirheumatic activity of curcumin (diferuloyl methane).

Authors:  S D Deodhar; R Sethi; R C Srimal
Journal:  Indian J Med Res       Date:  1980-04       Impact factor: 2.375

10.  Three inhibitors of type 1 human immunodeficiency virus long terminal repeat-directed gene expression and virus replication.

Authors:  C J Li; L J Zhang; B J Dezube; C S Crumpacker; A B Pardee
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 12.779

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.